Indian pediatricsPub Date : 2025-07-01Epub Date: 2025-04-22DOI: 10.1007/s13312-025-00075-9
Vykuntaraju K Gowda, Halima Simin, Uddhava V Kinhal, G V Basavaraja, K S Sanjay
{"title":"Cannabidiol in Drug-Resistant Epilepsy (DRE) in Children: A Retrospective Study.","authors":"Vykuntaraju K Gowda, Halima Simin, Uddhava V Kinhal, G V Basavaraja, K S Sanjay","doi":"10.1007/s13312-025-00075-9","DOIUrl":"10.1007/s13312-025-00075-9","url":null,"abstract":"<p><strong>Objectives: </strong>To describe the effectiveness and tolerability of cannabidiol (CBD) in children with drug-resistant epilepsy (DRE).</p><p><strong>Methods: </strong>Records of children with DRE who received CBD for at least six months were reviewed. Reduction in seizure frequency [complete (> 90%), partial (30-90%), no response (< 30%)], parent reported adverse effects and discontinuation of CBD, if any, were noted.</p><p><strong>Results: </strong>Records of 50 children with DRE (Lennox-Gastaut syndrome 32, Dravet syndrome 4, and Tuberous sclerosis complex 2), mean (SD) age 7.8 (4.3) years were reviewed. Complete, partial, and no response to CBD was seen in 10, 18 and 14 children; 8 became seizure-free. Eight children discontinued treatment due to lack of efficacy (n = 4), by increased adverse effects (n = 3) and aggravation of seizures (n = 1). Adverse effects were noted in 22 (44%), none required hospitalization.</p><p><strong>Conclusion: </strong>Cannabidiol is a useful and safe add-on drug in children with DRE.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":"501-505"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143999428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Risk Stratification-Based Therapy for Children with E-beta Thalassemia: A 20-Year Follow-Up Study.","authors":"Kavitha Ganesan, Suresh Duraisamy, Anupama Nair, Vijayshree Muthukumar, Anurag Nalla Reddy, Minakshi Balwani, Nithya Seshadri, Ramya Uppuluri, Revathi Raj","doi":"10.1007/s13312-025-00089-3","DOIUrl":"10.1007/s13312-025-00089-3","url":null,"abstract":"<p><strong>Objective: </strong>To present risk stratification-based follow-up of children with E-beta thalassemia.</p><p><strong>Methods: </strong>Children with E-beta thalassemia between August 2002 and August 2022 were classified as mild, moderate, or severe disease using Mahidol scoring. Children in the moderate group with < 20 or ≥ 20 nucleated red blood cells (nRBCs) per 100 white blood cells were clubbed with mild or severe phenotype, respectively. Children with mild/moderate severity received hydroxyurea (HU) and those with severe disease received regular transfusions.</p><p><strong>Results: </strong>Out of 104 children (median age of onset 3.5 years), 30 (29%), 46 (44%), and 28 (27%) were categorized as mild, moderate, and severe disease, at initial presentation. Based on nRBC count, 27 and 19 children in moderate category were recategorized as mild to moderate and moderate to severe. Fifty-six, 19, and 29 children received HU, transfusions with HU, and monthly transfusion and chelation, respectively. At a median follow-up of 8 years, 67/93 (72%) children classified as \"mild to moderate\" remained well on HU, and 26/93 (28%) children classified as \"moderate to severe\" remained on regular transfusions.</p><p><strong>Conclusion: </strong>Using nRBCs in addition to Mahidol scoring can serve as a useful tool to individualize therapy.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":"506-510"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144142674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Serum Immunoglobulin Levels in Children with Acute Lymphoblastic Leukemia During Maintenance Chemotherapy and its Association with Severe Febrile Illness.","authors":"Maharshi Trivedi, Priyakumari Thankamony, Manjusha Nair, Binitha Rajeswari, Guruprasad Chellappan Sojamani, Shwetha Seetharam, Prasanth Varikkattu Rajendran, Jagathnath Krishna","doi":"10.1007/s13312-025-00034-4","DOIUrl":"10.1007/s13312-025-00034-4","url":null,"abstract":"<p><strong>Objective: </strong>To determine the proportion of children with acute lymphoblastic leukemia (ALL) with hypoglobulinemia during maintenance chemotherapy and to determine its association with severe febrile illnesses.</p><p><strong>Methods: </strong>Children with ALL receiving maintenance chemotherapy were prospectively recruited and serum immunoglobulin levels (IgG, IgM, IgA) were measured by turbidimetric method. Children were followed up for severe febrile illnesses for 6 months or till the completion of treatment.</p><p><strong>Results: </strong>We enrolled 199 children with mean (SD) age 82.03 (39.34) months; 58, 52, 47, and 42 children had received 0-6, 7-12, 13-18 and 19-24 months of maintenance chemotherapy, respectively. Hypo-IgG, hypo-IgA, and hypo-IgM were seen in 56.8%, 80.4%, and 86.4% of children. 91 (45.7%) children developed 147 episodes of severe febrile illness. Older age (> 5 years) was associated with decreased risk [odds ratio 95% CI] of hypo-IgG [0.540 (0.297, 0.982), P = 0.044], hypo-IgA [0.030 (0.011, 0.088), P = 0.001], and hypo-IgM [0.323 (0.117, 0.894), P = 0.030] and female gender had decreased risk of hypo-IgG (0.539 (0.305, 0.953), P = 0.033). Older age decreased the risk [0.585 (0.328, 1.041), P = 0.014] and girls were at increased risk [(1.118, 3.488), P = 0.019] of severe febrile illness. Hypoglobulinemia did not increase the risk of severe febrile illness.</p><p><strong>Conclusion: </strong>Hypoglobulinemia was not found to be an independent risk factor for severe febrile illnesses in children with ALL receiving maintenance chemotherapy.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":"482-488"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143991303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Adherence of Children to the Indian Academy of Pediatrics (IAP) Guidelines on Permissible Daily Screen Exposure-A Hospital-Based Cross-Sectional Study from Southern India.","authors":"Siva Sai Sushumna Veluguri, Diptirekha Satapathy, Thirunavukkarasu Arun Babu, Vinothkumar Kalidoss","doi":"10.1007/s13312-025-00097-3","DOIUrl":"10.1007/s13312-025-00097-3","url":null,"abstract":"<p><p>This study assessed the adherence to IAP guidelines on permissible daily screen exposure in 771 children aged 3 months to 14 years using a pre-validated questionnaire. The mean (SD) screen time (ST) was 2.62 (1.44) hours, with adherence rates of 1%, 8.8%, 3.2%, and 24.6% in children aged < 2 years, 2-5 years, 6-10 years, and 11-14 years, respectively. Factors like age, siblings, family size, school type, and home gadgets significantly influenced ST. Novel strategies and implementation techniques should be adopted to improve adherence among children.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":"528-530"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144150352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Vasoactive Ventilation Renal Score as a Predictor of Outcomes in Children Admitted to PICU: An Observational Study.","authors":"Shilpi Chauhan, Prerna Batra, Vikram Bhaskar, Piyush Gupta","doi":"10.1007/s13312-025-00076-8","DOIUrl":"10.1007/s13312-025-00076-8","url":null,"abstract":"<p><strong>Objectives: </strong>To determine the area under curve (AUC) for vasoactive ventilation renal score (VVRS) > 10 at 24-h of admission for predicting mortality in children aged 1-12 years admitted to pediatric intensive care unit (PICU). To also determine the AUC for VVRS > 10 at 48-h of admission for predicting mortality and to determine the AUC of VVRS > 10 at 24-h and 48-h of admission for predicting PICU stay > 3 days, hospital stay > 10 days and mechanical ventilation > 3 days.</p><p><strong>Methods: </strong>This observational study included 310 children aged 1-12 years admitted in PICU. All required parameters were noted, and VVRS, ventilation index and change in creatinine at 24-h and 48-h of admission were recoded. Receiver operating characteristic curves were computed to determine the predictive role of VVRS > 10 at 24-h and 48-h for mortality, duration of PICU stay, hospital stay and mechanical ventilation.</p><p><strong>Results: </strong>Seventy nine (25%) patients succumbed during the study. VVRS > 10 at 24-h and 48-h had a good predictive role for mortality with AUC of 0.873 (sensitivity 89.87%, specificity 69.70%) and 0.996 (sensitivity 96.20%, specificity 96.10%), respectively. Best cutoffs derived for VVRS (24-h), and VVRS (48-h) were > 2.5 and > 13.5. A higher AUC, sensitivity and specificity of VVRS at 48-h were observed for predicting prolonged PICU stay, duration of mechanical ventilation and hospital stay.</p><p><strong>Conclusions: </strong>VVRS at 24-h and 48-h has a good predictive role for mortality in children admitted to PICU.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":"495-500"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143989775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Indian pediatricsPub Date : 2025-07-01Epub Date: 2025-04-09DOI: 10.1007/s13312-025-00038-0
Shreya Gupta, Gouri Rao Passi
{"title":"Infantile Epileptic Spasms Syndrome Due to Neonatal Hypoglycemic Brain Injury: A Retrospective Audit.","authors":"Shreya Gupta, Gouri Rao Passi","doi":"10.1007/s13312-025-00038-0","DOIUrl":"10.1007/s13312-025-00038-0","url":null,"abstract":"<p><p>In this retrospective audit of 56 children with infantile epileptic spasms syndrome (IESS), neonatal hypoglycemic brain injury (NHBI) was the leading etiology (35.71%), followed by hypoxic ischemic encephalopathy (HIE) (25%). Other causes accounted for 30.3% cases. Hypotonia, visual concerns, and microcephaly were more prominent in NHBI-related IESS compared to HIE.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":"525-527"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143811402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Indian pediatricsPub Date : 2025-07-01Epub Date: 2025-05-12DOI: 10.1007/s13312-025-00085-7
Saroj Kumar Tripathy, Abhishek Kumar, Sarthak Das
{"title":"Resuscitation Following Drowning: Key Updates for Improved Outcomes from the American Heart Association (AHA) and the American Academy of Pediatrics (AAP) Guidelines.","authors":"Saroj Kumar Tripathy, Abhishek Kumar, Sarthak Das","doi":"10.1007/s13312-025-00085-7","DOIUrl":"10.1007/s13312-025-00085-7","url":null,"abstract":"<p><p>Drowning is one of the commonest causes of unintentional mortality in children, moreover in developing countries. We briefly highlight the 2024 major updates jointly by the American Heart Association (AHA) and the American Academy of Pediatrics (AAP) on resuscitation of drowning victims and the chain of survival.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":"542-546"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144009959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Indian pediatricsPub Date : 2025-07-01Epub Date: 2025-05-26DOI: 10.1007/s13312-025-00101-w
Akanksha Mahajan, Mukta Mantan
{"title":"An Update of the KDIGO Chronic Kidney Disease Guidelines 2024: Takeaway for Pediatricians.","authors":"Akanksha Mahajan, Mukta Mantan","doi":"10.1007/s13312-025-00101-w","DOIUrl":"10.1007/s13312-025-00101-w","url":null,"abstract":"<p><p>Revised KDIGO (Kidney Disease: Improving Global Outcomes) Chronic Kidney Disease (CKD) guidelines have been published in 2024 with salient modifications to the previous version published in 2012. The guidelines provide management details for both adults and children with CKD. Herein, we highlight the practice points for pediatric population.</p>","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":"537-541"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144142673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}